Moderna
MRNA
#205
Rank
S$141.18 B
Marketcap
S$348.93
Share price
7.25%
Change (1 day)
983.00%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$141.18 Billion

As of November 2026 Moderna has a market cap of S$141.18 Billion. This makes Moderna the world's 205th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026S$141.18 B802.03%
2025S$15.65 B-25.43%
2024S$20.99 B-58.08%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Nov 8th, 2026 the market cap of Moderna was reported to be:

S$129.89 Billion
by Nasdaq info icon info icon
S$129.89 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$859.27 B 508.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$392.80 B 178.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$465.83 B 229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
S$0.72 B-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.81 B-97.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S$1.06 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$26.61 B-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$8.61 B-93.90%๐Ÿ‡บ๐Ÿ‡ธ USA